Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cosmos Holdings ( (COSM) ) just unveiled an update.
On September 30, 2025, Cosmos Health Inc. appointed Theodoros C. Karkantzos as a member of its Board of Directors and the Nominating and Corporate Governance Committee. Mr. Karkantzos, who has over 15 years of experience in investment and business development, was elected at the annual general meeting of stockholders. His expertise includes finance, strategy, private equity, and asset management, and he holds distinguished academic qualifications from the University of Cambridge and the University of Warwick. The appointment is expected to enhance the company’s strategic direction, leveraging Mr. Karkantzos’s extensive experience in various sectors, including real estate and healthcare.
The most recent analyst rating on (COSM) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Cosmos Holdings stock, see the COSM Stock Forecast page.
Spark’s Take on COSM Stock
According to Spark, TipRanks’ AI Analyst, COSM is a Neutral.
Cosmos Holdings’ overall stock score is primarily impacted by its challenging financial performance, characterized by persistent net losses and negative cash flows. While technical analysis shows bullish momentum, the valuation remains unattractive due to the negative P/E ratio and lack of dividend yield. These factors collectively result in a moderate overall stock score.
To see Spark’s full report on COSM stock, click here.
More about Cosmos Holdings
Average Trading Volume: 932,305
Technical Sentiment Signal: Hold
Current Market Cap: $33.49M
For detailed information about COSM stock, go to TipRanks’ Stock Analysis page.